Downloaded from heart.bmj.com on February 14, 2011 - Published by group.bmj.com

Editorial

LVH response. Particularly striking has Left ventricular hypertrophy in been the observation that outcome is improved in animals undergoing aortic binding by blocking the hypertrophic aortic valve stenosis: friend or response to pressure overload.10 Although genetically modified animals have higher foe? left ventricular systolic stress than their wild-type counter mates, this has no consequence on long-term myocardial Raquel Yotti, Javier Bermejo performance. In fact, knock-out animals lived longer. The conventional conception ‘How wonderful that we have found (LVM) was found in 59% of patients from of physiological adaptation to pressure a paradox. Now we have some hope of an unselected cohort with asymptomatic overload as a teleological mechanism ’ making progress. AS. Multivariate analysis showed the to reduce wall stress thus calls for e Neils Böhr (1885 1962) independent predictive value of and inap- revision.11 12 Concentric remodelling (reduction of the propriate LVM, in addition to well estab- There are several mechanisms by which fl diameter/thickness ratio) and hyper- lished indices that in uence outcome in excessive LVH may be related to the 34 trophy (increase of massdleft ventricular AS such as baseline disease severity or outcome of patients with AS. It has been fi 5 hypertrophy; LVH) have been classically the degree of valve calci cation. Although shown that left ventricular systolic func- interpreted as the physiological mecha- a potentially maladaptive effect of hyper- tion declines as hypertrophy develops, 6 6 nisms used by the left ventricle to trophy in AS had already been reported, increasing the risk of heart failure. Due fi compensate for chronic pressure over- this is the rst study demonstrating its to afterload dependence, systolic chamber fi load.1 At the cellular level, increasing the detrimental impact on patient outcome in function may be dif cult to quantify in number of contractile elements improves a longitudinal design. the presence of AS. As left ventricular contractile force. At the organ level, In hypertensive heart disease, the dele- volumes become smaller due to concentric a thicker myocardial wall reduces left terious consequences of left ventricular remodelling, stroke volume is reduced, ‘ ventricular radial, circumferential and remodelling have been unequivocally sometimes leading to the paradoxical fl ’ 13 meridional systolic stresses. Concentric proved. Best evidence comes from phar- low- ow AS phenomenon. Despite remodelling and hypertrophy thus take macological interventions showing normal ejection fraction, patients with advantage of Laplace’s law to benefit a reduction of cardiovascular events this condition show higher values of systolic function. Even under extreme parallel to the regression of LVH, inde- concentric remodelling and smaller 7 fl values of intraventricular pressure, overall pendent of their effect on blood pressure. ventricles than their normal- ow coun- fl systolic performance is maintained and A relatively large number of patients with terparts. In paradoxical low- ow AS, pump function remains normal in terms hypertension also develop inappropriate reduced output is believed to result in of cardiac output and filling pressures. In hypertrophy for the degree of load and, as the combination of systolic and diastolic the long term, if the systolic load is not in AS, the correlation of LVM with dysfunction. Under stress situations, the relieved, this compensatory mechanism outcome may not be linear. In fact, heart may fail to provide adequate output, fl fails, hypertrophy switches towards adverse inappropriate hypertrophy and patients with paradoxical low- ow eccentric remodelling, filling pressures rise beyond a given threshold had previously AS show an adverse prognosis, particu- and overt heart failure develops (a phase been described in hypertensive heart larly if they do not undergo valve 14 classically designated ‘afterload disease, and excessive LVM correlates with replacement. mismatch’). This has been the classic cardiovascular outcome, independently of Hypertension and AS frequently 8 conception of the favourable ‘adaptive’ conventional risk factors. coexist, and both conditions share effects of left ventricular remodelling A number of genetic, molecular, and a number of common mechanisms. They under increased systolic stress.1 cellular mechanisms related to secondary also multiply their effect on the systolic In their article published in this issue of LVH have been well characterised in the burden of the left ventricle. In fact, AS Heart, Cioffi et al2 (see page 301) analyse past few years. Interestingly, separate patients with hypertension show more the prognostic value of LVH in a prospec- intracellular pathways have been identi- unfavourable remodelling than normo- fi 15 tive cohort of patients with aortic valve ed to modulate adaptive and maladaptive tensive individuals. This has led some 9 stenosis (AS). The major finding of their hypertrophy. Signalling molecules that authors to propose combined indices of e study is related to adverse outcome if involve the phosphoinositide-3-kinase systolic load such as the valvular vascular values are 110% higher than the values cascade exert a protective role in progres- impedance, which may allow prognosis fi expected for wall stress, body size and sion towards heart failure, whereas path- to be strati ed in given subsets of patients 16 gender. Importantly, such an inappro- ways involving G-protein signalling with AS. However, even these more priate increase in left ventricular mass enhance apoptosis and extracellular sophisticated measurements of systolic fibrosis. Further understanding of these load only consider singular measurements molecular mechanisms will help drug at a given time point. Indices accounting development to prevent the transition for the degree of left ventricular Department of Cardiology, Hospital General Universitario from left ventricular concentric remodel- remodelling and LVM may have the Gregorio Maran˜o´n, Madrid, Spain ling to heart failure. In addition, clarifica- advantage of reflecting the effects of an Dr Javier Bermejo, Department of Correspondence to tion of the signal pathways of LVH has abnormal load during a long period of Cardiology, Hospital General Universitario Gregorio ‘ Maran˜o´n, Dr Esquerdo 46, 28007 Madrid, Spain; allowed investigators to develop geneti- time, acting as a cumulative systolic load [email protected] cally modified murine models of blunted dose’ indicators.

Heart February 2011 Vol 97 No 4 269 Downloaded from heart.bmj.com on February 14, 2011 - Published by group.bmj.com

Editorial

Localised LVH at the basal septum is surgery.29 Patients are also sometimes overload hypertrophy prevent cardiac dysfunction particularly prevalent in hypertensive operated on when myocardial damage is despite increased wall stress. Circulation 17 2002;105:85e92. patients with AS, and may occasionally already irreversible. Current European 11. Buermans HP, Paulus WJ. Iconoclasts topple cause associated subvalvular outflow practice guidelines accept severe LVH (in adaptive myocardial hypertrophy in aortic stenosis. obstruction (‘double outflow stenosis’), the absence of hypertension) as a IIb Eur Heart J 2005;26:1697e9. thus accelerating patient symptom devel- (level of evidence C) class recommendation 12. Sano M, Schneider MD. Still stressed out but doing opment. Even milder and non-obstructive for valve replacement in asymptomatic fine: normalization of wall stress is superfluous to maintaining cardiac function in chronic pressure 30 fi degrees of basal septal hypertrophy may patients. However, the study by Ciof overload. Circulation 2002;105:8e10. 18e20 2 be detrimental. Significant reductions et al suggests that efforts should be made 13. Dumesnil JG, Pibarot P, Carabello B. Paradoxical low of annular size (most frequently found in to explore further the role of more refined flow and/or low gradient severe aortic stenosis female patients with an advanced measurements of ventricular remodelling despite preserved left ventricular ejection fraction: implications for diagnosis and treatment. Eur Heart J concentric remodelling pattern) may in prospective clinical trials. The prog- 2010;31:281e9. complicate therapeutic interventions, nostic value of ventricular variables beyond 14. Hachicha Z, Dumesnil JG, Bogaty P, et al. increasing the risk of patienteprosthesis ejection fraction need to be analysed, and Paradoxical low-flow, low-gradient severe aortic mismatch,18 or precluding transcatheter surrogate indices such as systolic pulmo- stenosis despite preserved ejection fraction is 31 associated with higher afterload and reduced survival. valve implantation. Importantly, LVH and nary artery pressure or natriuretic e 32 Circulation 2007;115:2856 64. concentric remodelling are associated with peptides are particularly promising. 15. Rieck AE, Cramariuc D, Staal EM, et al. Impact of increased perioperative and mid-term Although the level of evidence is currently hypertension on left ventricular structure in patients mortality.19 20 too weak to recommend anticipating with asymptomatic aortic valve stenosis (a SEAS e The worse prognosis associated with surgery in the asymptomatic patient based substudy). J Hypertens 2010;28:377 83. 16. Hachicha Z, Dumesnil JG, Pibarot P. Usefulness of inappropriately high LVM in AS may also only on the degree of hypertrophy, the left the valvuloarterial impedance to predict adverse be due to factors not related to the valve ventricular remodelling response should no outcome in asymptomatic aortic stenosis. J Am Coll disease per se. Aortic valve sclerosis is longer be considered only as a favourable Cardiol 2009;54:1003e11. associated with increased cardiovascular adaptive mechanism to AS. 17. Tuseth N, Cramariuc D, Rieck AE, et al. Asymmetric e risk,21 and this association may be partic- septal hypertrophy a marker of hypertension in Competing interests None. aortic stenosis (a SEAS substudy). Blood Press ularly powerful in patients with excessive e Provenance and peer review Commissioned; not 2010;19:140 4. remodelling. Two recent studies have externally peer reviewed. 18. Kulik A, Al-Saigh M, Chan V, et al. Enlargement of shown that obesity22 and metabolic the small aortic root during aortic valve replacement: 23 Published Online First 6 December 2010 is there a benefit? Ann Thorac Surg syndrome correlate to LVM, in addition e Heart 2011;97:269e271. doi:10.1136/hrt.2010.205575 2008;85:94 100. to conventional cardiovascular risk factors 19. Mehta RH, Bruckman D, Das S, et al. Implications of such as age, sex and low-density choles- increased left ventricular mass index on in-hospital terol. Inappropriately high LVM may thus outcomes in patients undergoing aortic valve surgery. be a flagging signal of a particularly high REFERENCES J Thorac Cardiovasc Surg 2001;122:919e28. 1. Sasayama S, Ross J Jr, Franklin D, et al. Adaptations vascular risk factor profile in a given 20. Orsinelli DA, Aurigemma GP, Battista S, et al. Left of the left ventricle to chronic pressure overload. Circ ventricular hypertrophy and mortality after aortic valve patient with AS. Res 1976;38:172e8. replacement for aortic stenosis. A high risk subgroup Some therapeutic consequences may be 2. Cioffi G, Faggiano P, Vizzardi E, et al. Prognostic identified by preoperative relative wall thickness. considered in patients with AS showing effect of inappropriately high left ventricular mass J Am Coll Cardiol 1993;22:1679e83. inappropriate LVM. Concomitant hyper- in asymptomatic severe aortic stenosis. Heart 21. Otto CM, Lind BK, Kitzman DW, et al. Association of 2011;97:301e7. aortic-valve sclerosis with cardiovascular mortality tension deserves treatment, attempting to 3. Bermejo J, Odreman R, Feijoo J, et al. Clinical and morbidity in the elderly. N Engl J Med slow down the remodelling process. efficacy of Doppler-echocardiographic indices of 1999;341:142e7. Importantly, AS severity may need to be aortic valve stenosis: a comparative test-based 22. Lund BP, Gohlke-Barwolf C, Cramariuc D, et al. reassessed once blood pressure is analysis of outcome. J Am Coll Cardiol Effect of obesity on left ventricular mass and 24 2003;41:142e51. systolic function in patients with asymptomatic controlled. ACE inhibitors show a suit- 4. Otto CM, Burwash IG, Legget ME, et al. Prospective fi aortic stenosis (a Simvastatin Ezetimibe in Aortic able haemodynamic pro le in asymptom- study of asymptomatic valvular aortic stenosis. Stenosis [SEAS] substudy). Am J Cardiol atic hypertensive AS patients, if titrated Clinical, echocardiographic, and exercise predictors of 2010;105:1456e60. with caution.25 When present, hyper- outcome. Circulation 1997;95:2262e70. 23. Page A, Dumesnil JG, Clavel MA, et al. Metabolic cholesterolaemia and metabolic syndrome 5. Rosenhek R, Binder T, Porenta G, et al. Predictors of syndrome is associated with more pronounced outcome in severe, asymptomatic aortic stenosis. impairment of left ventricle geometry and function in should also be intensively treated, despite N Engl J Med 2000;343:611e17. patients with calcific aortic stenosis: a substudy of the fact that statins will not slow valve 6. Kupari M, Turto H, Lommi J. Left ventricular the ASTRONOMER (Aortic Stenosis Progression disease progression.26 27 After valve hypertrophy in aortic valve stenosis: preventive or Observation Measuring Effects of Rosuvastatin). JAm replacement, pharmacological treatment promotive of systolic dysfunction and heart failure? Coll Cardiol 2010;55:1867e74. Eur Heart J 2005;26:1790e6. should not be discontinued, as vasodila- 24. Bermejo J. The effects of hypertension on aortic 7. Mathew J, Sleight P, Lonn E, et al. Reduction of valve stenosis. Heart 2005;91:280e2. tors may accelerate favourable reverse cardiovascular risk by regression of 25. Jimenez-Candil J, Bermejo J, Yotti R, et al. Effects 28 remodelling. electrocardiographic markers of left ventricular of angiotensin converting enzyme inhibitors in Of particular controversy is how the hypertrophy by the angiotensin-converting enzyme hypertensive patients with aortic valve stenosis: e e degree of LVH should influence timing for inhibitor ramipril. Circulation 2001;104:1615 21. a drug withdrawal study. Heart 2005;91:1311 18. 8. de Simone G, Verdecchia P, Pede S, et al. Prognosis 26. Chan KL, Teo K, Dumesnil JG, et al. Effect of lipid surgery. Current decision making based on of inappropriate left ventricular mass in hypertension: lowering with rosuvastatin on progression of aortic symptomatic status, disease severity and the MAVI Study. Hypertension 2002;40:470e6. stenosis: results of the aortic stenosis progression left ventricular ejection fraction works fine 9. Selvetella G, Hirsch E, Notte A, et al. Adaptive and observation: measuring effects of rosuvastatin in most patients with AS. However, there maladaptive hypertrophic pathways: points of (ASTRONOMER) trial. Circulation 2010;121:306e14. convergence and divergence. Cardiovasc Res is probably room for improvement, 27. Rossebo AB, Pedersen TR, Boman K, et al. 2004;63:373e80. Intensive lipid lowering with simvastatin and because patients still die from the compli- 10. Esposito G, Rapacciuolo A, Naga Prasad SV, et al. ezetimibe in aortic stenosis. N Engl J Med cations of AS without ever undergoing Genetic alterations that inhibit in vivo pressure- 2008;359:1343e56.

270 Heart February 2011 Vol 97 No 4 Downloaded from heart.bmj.com on February 14, 2011 - Published by group.bmj.com

Editorial

28. Dahl JS, Videbaek L, Poulsen MK, et al. Effect of 30. Vahanian A, Baumgartner H, Bax J, et al. Guidelines prognostic implications. J Am Coll Cardiol candesartan treatment on left ventricular remodeling on the management of valvular heart disease: the 2002;40:789e95. after aortic valve replacement for aortic stenosis. Am Task Force on the Management of Valvular Heart 32. Talwar S, Downie PF, Squire IB, et al. J Cardiol 2010;106:713e19. Disease of the European Society of Cardiology. Eur Plasma N-terminal pro BNP and cardiotrophin-1 are 29. Stewart RA, Kerr AJ, Whalley GA, et al. Left Heart J 2007;28:230e68. elevated in aortic stenosis. Eur J Heart Fail ventricular systolic and diastolic function assessed by 31. Malouf JF, Enriquez-Sarano M, Pellikka PA, et al. 2001;3:15e19. tissue Doppler imaging and outcome in asymptomatic Severe pulmonary hypertension in patients with aortic stenosis. Eur Heart J 2010;31:2216e22. severe aortic valve stenosis: clinical profile and

Heart February 2011 Vol 97 No 4 271 Downloaded from heart.bmj.com on February 14, 2011 - Published by group.bmj.com

Left ventricular hypertrophy in aortic valve stenosis: friend or foe?

Raquel Yotti and Javier Bermejo

Heart 2011 97: 269-271 originally published online December 6, 2010 doi: 10.1136/hrt.2010.205575

Updated information and services can be found at: http://heart.bmj.com/content/97/4/269.full.html

These include: References This article cites 32 articles, 25 of which can be accessed free at: http://heart.bmj.com/content/97/4/269.full.html#ref-list-1 Email alerting Receive free email alerts when new articles cite this article. Sign up in service the box at the top right corner of the online article.

Notes

To request permissions go to: http://group.bmj.com/group/rights-licensing/permissions

To order reprints go to: http://journals.bmj.com/cgi/reprintform

To subscribe to BMJ go to: http://group.bmj.com/subscribe/